Ahmed M Elshazly

16PUBLICATIONS
13CO-AUTHORS
AutoimmunityMolecular targetsSpeech recognitionCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (16)

|Jul 24, 2026
Cytostatic autophagy: an underappreciated form of autophagy and its ramifications in cancer.

|May 27, 2026
Mcl1 as a Molecular Switch Linking Inflammatory Bowel Diseases to Colorectal Tumorigenesis.

|May 11, 2026
Proteasome inhibition enhances lysosome-mediated targeted protein degradation.

|May 04, 2026
Turning adaptive resistance into vulnerability: AUTAC-Mediated degradation of Mcl1.

|Nov 09, 2024
A BPTF Inhibitor That Interferes with the Multidrug Resistance Pump to Sensitize Murine Triple-Negative Breast Cancer Cells to Chemotherapy.

Melanie M Sinanian, Afshan Rahman, Ahmed M Elshazly

|Sep 14, 2024
Is Autophagy Targeting a Valid Adjuvant Strategy in Conjunction with Tyrosine Kinase Inhibitors?

Ahmed M Elshazly, Jingwen Xu, Nebras Melhem

Pageof 3

Frequent Collaborators

10 joint publications

David A Gewirtz

5 joint publications

Senthil K Radhakrishnan

3 joint publications

Tareq Saleh

2 joint publications

Hisashi Harada